ACADIA Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc.
| ACADIA Pharmaceuticals Inc. |
| Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd. |
| 1:2020cv00986 |
| July 24, 2020 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on September 21, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 16 ANSWER to #12 Answer to Complaint, Counterclaim by ACADIA Pharmaceuticals Inc..(Taylor, James) |
| Filing 15 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: June 11, 2020. Date of Expiration of Patent: August 24, 2026 and September 26, 2025. (Keller, Karen) |
| Filing 14 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,659,285 B2 ;US 7,923,564 B2 . (Keller, Karen) |
| Filing 13 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| Filing 12 ANSWER to #1 Complaint, Affirmative Defenses and COUNTERCLAIMS against ACADIA Pharmaceuticals Inc. by Teva Pharmaceuticals USA, Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B)(Keller, Karen) Modified on 9/1/2020 (nms). |
| Pro Hac Vice Attorneys Michael K. Nutter, Ivan M. Poullaos, Linda A. Greene, Katherine D. Hundt for Teva Pharmaceuticals USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
SO ORDERED, re #11 MOTION for Pro Hac Vice Appearance of Attorney Michael Nutter, Ivan Poullaos, Linda Greene and Katherine D. Hundt, filed by Teva Pharmaceuticals USA, Inc.. Signed by Judge Richard G. Andrews on 8/13/2020. (nms)
|
| Filing 11 MOTION for Pro Hac Vice Appearance of Attorney Michael Nutter, Ivan Poullaos, Linda Greene and Katherine D. Hundt - filed by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| Filing 10 STIPULATION TO EXTEND TIME to move, plead, or otherwise respond to the Complaint to August 31, 2020 - filed by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
|
SO ORDERED, re #10 STIPULATION TO EXTEND TIME to move, plead, or otherwise respond to the Complaint to August 31, 2020 (*Reset Answer Deadlines: Teva Pharmaceuticals USA, Inc. answer due 8/31/2020). Signed by Judge Richard G. Andrews on 8/6/2020. (nms)
|
|
Filing 9
SO ORDERED Granting #8 Stipulation of Dismissal (*Party Teva Pharmaceutical Industries Ltd. terminated). Signed by Judge Richard G. Andrews on 8/4/2020. (nms)
|
| Filing 8 STIPULATION of Dismissal as to Teva Pharmaceutical Industries Limited and Amendment of Caption, by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Keller, Karen) Modified on 8/4/2020 (nms). |
| Pro Hac Vice Attorneys Chad J. Peterman, Bruce M. Wexler, Scott F. Peachman for ACADIA Pharmaceuticals Inc. and ACADIA Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-00986-RGA, 1:20-cv-00985-RGA(kmd) |
| CORRECTING ENTRY: Added Related Cases per Letter Dated 7/31/20. Associated Cases: 1:20-cv-00986-RGA, 1:20-cv-00985-RGA, 1:20-cv-01021-UNA, 1:20-cv-01022-UNA, 1:20-cv-01029-UNA(rwc) |
| Filing 7 MOTION for Pro Hac Vice Appearance of Attorney Chad J. Peterman, Bruce M. Wexler and Scott F. Peachman - filed by ACADIA Pharmaceuticals Inc.. (Taylor, James) |
|
SO ORDERED, re #7 MOTION for Pro Hac Vice Appearance of Attorney Chad J. Peterman, Bruce M. Wexler and Scott F. Peachman, filed by ACADIA Pharmaceuticals Inc.. Signed by Judge Richard G. Andrews on 7/30/2020. (nms)
|
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:20-cv-00985-RGA, 1:20-cv-00986-RGA (rjb) |
| Filing 6 SUMMONS Returned Executed by ACADIA Pharmaceuticals Inc.. Teva Pharmaceuticals USA, Inc. served on 7/27/2020, answer due 8/17/2020. (Taylor, James) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by ACADIA Pharmaceuticals Inc.. (Taylor, James) |
| No Summons Issued. (myr) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,601,740 ;7,732,615 ;10,449,185 ;10,646,480. (myr) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: June 17, 2020. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: December 17, 2022 (statutory)October 29, 2023 (extended)(myr) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr) |
| Filing 1 COMPLAINT filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3084902.) - filed by ACADIA Pharmaceuticals Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Civil Cover Sheet)(myr) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
